As of Friday close, Acelyrin Inc.’s (NASDAQ:SLRN) stock was down -$0.39, moving down -1.45 percent to $26.55. The average number of shares traded per day over the past five days has been 957,560 shares. 3 times new highs have been achieved over the past 5 days, with a $1.60 gain in that time frame. In the last twenty days, the average volume was 757,560, while in the previous 50 days, it was 766,974.
Since last month, SLRN stock rose 21.90%. Shares of the company fell to $21.38 on 07/20/23, the lowest level in the past month. Since the beginning of this year, SLRN’s stock price has risen by 12.98%. However, the stock has declined by -5.88% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
SLRN stock investors should be aware that Acelyrin Inc. (SLRN) stock had its last reported insider trading activity 102 days ago on May 09. Westlake BioPartners Fund II,, the 10% Owner of the company, purchased of 1,250,000 shares for $18.00 on May 09. It resulted in a $22,500,000 investment by the insider. SEIDENBERG BETH C added 1,250,000 shares at an average price of $18.00 on May 09. The insider now owns 9,790,729 shares following the transaction. On May 09, Director SEIDENBERG BETH C bought 60,000 shares at $18.00 apiece. The transaction was valued at $1,080,000.
Financial Health
In the three months ended June 29, Acelyrin Inc.’s quick ratio stood at 8.70, while its current ratio was 8.70, showing that the company is able to pay off its debt.
While analysts expected Acelyrin Inc. to report -$0.76 quarterly earnings, the actual figure was -$0.4 per share, beating the consensus estimate by 47.40%. The liabilities of Acelyrin Inc. were 34.06 million at the end of its most recent quarter ended June 29. The value of shareholders’ equity is $97.24 million.
Technical Picture
This quick technical analysis looks at Acelyrin Inc.’s (SLRN) price momentum. With a historical volatility rate of 43.40%, the RSI 9-day stood at 67.29% on 18 August.
With respect to its five-day moving average, the current Acelyrin Inc. price is up by +6.41% percent or $1.60. At present, SLRN shares trade +14.49% above its 20-day simple moving average. However, the stock is currently trading approximately +56.45% above its SMA50.
Stochastic coefficient K was 72.26% and Stochastic coefficient D was 73.46%, while ATR was 1.67. Given the Stochastic reading of 66.87% for the 14-day period, the RSI (14) reading has been calculated as 65.58%. As of today, the MACD Oscillator reading stands at 1.00, while the 14-day reading stands at 1.48.
Analyst Ratings
TD Cowen launched its rating on Acelyrin Inc. (NASDAQ: SLRN) to an Outperform in a note to investors on May 30, 2023. Acelyrin Inc. (SLRN) has been rated Buy by analysts. According to 0 brokerage firms, SLRN is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Acelyrin Inc. stock as buy, with 4 recommending it as overweight.
With a median target price of $31.00, the current consensus forecast for the stock is $29.00 – $68.00. Based on these forecasts, analysts predict Acelyrin Inc. (SLRN) will achieve an average price target of $42.67.
